BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Pd98059

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one [Supplementary Concept] inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source

7+ PubMed studies analyzed · Evidence Score: 20.8

Research Domains

Pd98059 has been studied across 3 research domains including 🦴 Bone & Joint, 🔬 Oncology, 🔬 Inflammation. The primary research focus is 🦴 Bone & Joint with 71% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Pd98059, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

daph
9 shared targets
Pueraria
13 shared targets
trametinib
5 shared targets
Melphalan
13 shared targets
arctigenin-4-O-(3''-O-acetyl-beta-D-glucoside)
7 shared targets
Thioinosine
8 shared targets
Thiabendazole
8 shared targets
Pseudoephedrine
7 shared targets
Genistein
14 shared targets
Leflunomide
11 shared targets
Loading evidence profile...

This evidence profile for Pd98059 is generated deterministically from 7 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.